Annals of RSCB Vol. XV, Issue 2
|
|
- Emil Miles
- 6 years ago
- Views:
Transcription
1 IMUNOHISTOCHEMICAL STUDY ON BARRETT S OESOPHAGUS SEQUENCE DYSPLASIA GASTRO-ESOPHAGEAL ADENOCARCINOMA Doina-Carina Voinescu 1, Carmen Popescu 2, Sajjad Yousaf 3, Elena Cioboată 3, B. Pintilie 3, M. Cruce UNIVERSITY OF MEDECINE AND PHARMACY OF GALATI 2 - LABORATORY OF PATOLOGY, No. 1 EMERGENCY HOSPITAL OF CRAIOVA 3 - UNIVERSITY OF MEDECINE AND PHARMACY OF CRAIOVA Summary The etiology of gastro-esophageal adenocarcinomas is related to gastro-esophageal reflux disease and the development of Barrett s esophagus or cardia intestinal metaplasia, a pre-neoplasic condition which is diagnosed endoscopically with an histological confirmation, an incomplete intestinal metaplasia. The medical societies have recommanded endoscopic cancer surveillance routinely for pacients with Barrett s metaplasia or cardiac intestinal metaplasia. Earlier detection of the metaplasia-dysplasia-gastro-esophageal adenocarcinoma and distinction between Barrett s metaplasia and cardia intestinal metaplasia are essential for the aplication of the prophylaxis of malignant transformation. The rising incidence and poor prognosis of gastro-esophageal adenocarcinomas have intensified research into earlier methods of detection of this diseases and the relationship to Barrett s esophagus. In the present study we investigates several immunohistochemical features of gastro-esophageal adenocarcinomas, 87 resection specimens of Barrett s esophagus and adenocarcinoma junction were carefully selected. We chosed the immunohistochemical study for MUC1, MUC2 and MUC5AC mucins for evidence the lesions of Barrett's oesophagus sequence dysplasia adenocarcinoma and the potential of utilization in the early detection of gastroesophageal adenocarcinomas junction. Keywords: Barrett s oesophagus; cardiac intestinal metaplasia; dysplasia; adenocarcinoma junction; immunohistochimical methods. doina_voinescu@yahoo.com Introduction Barretts's oesophagus represents the replacement of the normal squamous epithelium of the lower oesophagus by specialised intestinal metaplasia, under the influence of chronic gastro-oesophageal reflux (Spechler et al., 1996; Weinstein et al., 1996; Kim et al., 1997; DeMeester et al., 2000). Barrett s oesophagus is a premalignant condition that predisposes to the development of oesophageal adenocarcinoma. The intestinal metaplasia of the gastroesophageal junction, as a result of a chronic inflammation, irrespective of etiology, is considered an important risk factor for the development of the lesion towards dysplasia and gastroesophageal carcinoma junction. Dysplazia is a histopatological marker for the early diagnosis of adenocarcinoma at the level of gastro-oesophageal junction, as evidenced by the simultaneous presence of the same resection pieces on both dysplasia and neoplasia (Sampliner 1998; Spechler, 2002). 252
2 According to the World Health Organization, the gastro-oesophageal adenocarcinoma's junction are represented by: the distal oesophagus adenocarcinoma, the gastric cardia adenocarcinoma and the undercardia adenocarcinoma. The distal oesophagus adenocarcinoma and gastric cardia adenocarcinoma seem to predominate in the case of Caucasian men (M:F=7:1) (Blot et al, 1991; Lagergren, 2005), with a similar average age (56-62 years), the diagnosis being late - in advanced stages of disease and the prognosis being unfavorable, with 5-year mortality rates exceeding 80% (Ruol et al, 2000). Surgical cure rates (subtotal esophagectomy and proximal gastrectomy) are compromised by the fact that most patients are diagnosed at the late stage of disease of the delayed onset of symptoms. In this study I have made a detailed analysis within 87 cases of Barretts's oesophagus sequence - dysplasia adenocarcinoma at the level of gastrooesophageal junction. The immunohistochimical study included the analysis for MUC1, MUC2 and MUC5AC mucins, the markers possible useful for the precocious diagnosis of Barrett's oesophagus sequence dysplasia junctional adenocarcinoma. Materials and methods Patients The material for this study is based on the oesophagian biopsy specimens collected from the gastro-oesophageal sections and on the surgical resection specimens; the material has been worked out in the Histopatological Laboratory from No. 1 Emergency Hospital of Craiova and within the framework of Victor Babes Institute of Bucharest. Between from 587 of cases diagnosed with gastric cancer we selected 68 cases of gastro-oesophageal adenocarcinoma junction. Also from 154 cases diagnosticated in the same periode with oesophagian biopsy, we selected 19 cases of benign and malignant Barrett's oesophagus. The patients included in this study presented symptoms of gastro-esophageal reflux disease which included: heartburn and regurgitation at least twice within 1 week and persisted at least six months, all the symptoms could be relieved significantly with H2 receptor blocker or proton pump inhibitor, odynophagia with progresiv dysphagia addition decrease weight, occult haemorrhages (seldom). Endoscopy and biopsy protocol Endoscopic dates included macroscopic changes to the gastro-esophageal junction: a red velvety mucosa it can extend either circumferentially or as one or several tongues, polipoid lesions, ulcerations, presence or absence of hiatus hernia. For each resection specimen a sample of tumor tissue and normal tissue was available in paraffin embedded slides. The biopsy protocols included four quadrant biopsies at 2 cm levels in distal esophagus above and below the esophagogastric junction and sample of normal tissue. Specimens were fixed in 10% buffered formalin, embedded in paraffin wax and carefully microdisected. The paraffin sections used for the immunohistological exam were realized at 2 µm. They were mounted on glass slides treated with poly-l-lysine (SIGMA). Immunohistochemistry for MUC1, MUC2 and MUC5AC mucins We performed immunostaining on formalin fixed, paraffin embedded tissue sections using the immuno-enzyme polymer method name LSAB/HRP(Universal DAKO Labbeled Streptavidin Biotin 2 System Horseradish Peroxidase). Five-micrometer-thick serial sections were cut from each paraffinembedded block. The sections were deparaffinized in xylene and rehydrated through graded concentrations of alcohol slides were incubated in 3% hydrogen peroxide for 20 min to block nonspecific background staining due to endogenous peroxidase. Antigen retrieval was 253
3 performed by using 10 mm citrate buffer, ph 6.0 for min in microwave. Using the standard streptavidin-biotin peroxidase complex method were performed on all slides, were incubated for 30 minutes in secondary antibody solution. Diaminobenzidine (DAB) was used as a chromogen and developed a brown precipitate, very fine, localizing the antigen searched in the cytoplasm. The slides were counterstained with Mayer s hematoxylin. Negative controls were counterstained with the same tumor samples and staining methods by omitting the primary antibodies. The antibodies used in immunohistological studies have identified the molecular biomarkers followed for the research of Barretts's oesophagus sequence dysplasia adenocarcinoma junction; the positive expression was represented by the membranar, cytoplasmic and nuclear brown precipitate. The antibodies and the working parameters are described in Table 1. Table 1: The selected polyclonal antibodies and sera and working parameters was : ANTIBODY PRODUCER DILUTION CLONE PECULIARITY MUC 1 Novocastra 1:100 Ma 695 mucus epithelial tissue MUC 2 Novocastra 1:100 Ccp 58 mucus epithelial tissue MUC 5AC Neomarkers 1:50 45M1 mucus epithelial tissue Mucins, intense glycosylated proteins, represent the major components of mucus covering the luminal epithelial tissues. Synthesis and secretion of mucins are characteristic of glandular epithelial tissues. In our study we used monoclonal antibodies like MUC-1, MUC-2 and MUC-5AC. MUC1 glycoproteine is a type of breast apomucin also known as DF3 antigen. We used a monoclonal antibody-type of MUC1 glycoprotein, clone Ma695, using LSAB + technique in 1:100 dilution. For positive control of this reaction we included in the study a fragment of the endometrium. Immunopositivation showed a cytoplasmic and membrane pattern. MUC 2 glycoprotein is an intestinal apomucin which is not synthesized by normal gastric mucosa. I worked with the antibody-type glycoprotein MUC-2, clone ccp58 in 1:100 dilution. Primary antibody incubation time was 60 minutes at room temperature. The immunohistology reactions showed a cytoplasmic and membrane staining pattern. Mucin 5AC (MUC5AC) / B-1 gastric mucin outlined in mucosecretant columnar cells of surface gastric epithelium and in caliciform cells of fetal colon or in cells of colon that presents various precancerous lesions. In our study we used monoclonal antibody MUC5AC, clone 45M1 in dilution 1:50. I got positive imunoreacţii cytoplasm and the cell surface. Results From 87 cases of the current study it was identified 19 cases of Barrett s oesophagus with benign (16) and malignant lesions (3). Also, there were 68 cases of adenocarcinoma junction divided topographically: at the distal esophagus (3 cases), at the junction (48 cases) and subcardial (17 cases). To monitor the degree of dysplasia was preferred the classification defined by Riddell et al., (1983) and the distribution of 19 cases is shown in Table
4 Annals of RSCB Vol. XV, Issue 2 Table 2. The correlation between the degree of dysplasia and the number of cases in the study The degree of dysplasia Nondisplasic Barrett oesophagus Low- grade dysplasia Barrett (LGD) High- grade dysplasia Barrett (HGD) Oesophageal adenocarcinoma Indefinite for dysplasia Number of cases In the 68 cases of esophageal adenocarcinoma junction subject in the current study we identified the histopathologic type in accord to Lauren P classification (table 3). According to the World Health Organization, 68 cases of junctional adenocarcinoma were divided into three groups : G1 well differentiated adenocarcinoma (29 cases), G2- moderate differentiated adenocarcinoma (23 cases) and G3weak differentiated adenocarcinoma (16 cases). Mucinous adenocarcinomas, the undifferentiated frome those with "signet ring" with a tumoral component greater than 5% were included in G3. Table 3. Histopathological type of gastro-oesophageal adenocarcinoma junction Histopathological type Nr. of cases 52 7 Tubulopapillary Signet ring Mucinos 4 Undifferentiated 5 The results of immunohistochimical study of MUC1, MUC2 and MUC5AC mucins revealed that : MUC5AC expression is strong diffuse in Barrett's oesophagus. The MUC2 expression is constantly negative and MUC1 expression is focal positive and inconstant in Barrett's oesophagus (Figure 1; 2). Also, the MUC1 expression is strong positive in G2 (3 cases) and G3 (16 cases) adenocarcinoma (Figure 3; 4) and MUC2 expression is positive in mucinos adenocarcinoma (4 cases). Figure 1. Positive MUC1 immunostaining in glandular Barrett epithelium and absent MUC1 immunostaining in squamous epithelium. Cytoplasmic and membranar brown immunostaining that localize the antigen. IHC staining, ABC complex, counterstain by Mayer s haematoxylin. Ob. 40x 255
5 Annals of RSCB Vol. XV, Issue 2 Figura 2. Positive MUC5AC immunostaining in glandular Barrett epithelium. Cytoplasmic and membranar brown immunostaining that localize the antigen. IHC staining, ABC complex, counterstain by Mayer s haematoxylin. Ob. 40x Figure 3. Strong positive MUC1 immunostaining in moderate differentiated adenocarcinoma G2 (săgeată). Cytoplasmic and membranar brown immunostaining that localize the antigen. IHC staining, ABC complex, counterstain by Mayer s haematoxylin. Ob. 40x 256
6 Figure 4. Positive MUC1 immunostaining in weak differentiated adenocarcinoma G3. Cytoplasmic and membranar brown immunostaining that localize the antigen. IHC staining, ABC complex, counterstain by Mayer s haematoxylin. Ob. 100x Immunohistochimical expression of mucins is shown in Table 4. Table 4. Immunohistochimical expression of MUC1, MUC2 and MUC5AC mucins. Total cases adenocarcinoma Localisation Nr. cases MUC1 MUC2 MUC5AC /+ + Distal oesophagus /+ + Gastro-esophageal junction Undercardial /+ + Barrett's Metaplasia Present /+ + Missing/absent /+ + histopathological type Tubulopapillary /+ ++ Signet ring 7 -/+ -/+ ++ Mucinos Undifferentiated /+ weak positive or absent ;+ weak positive; ++ moderate ; +++strong positive 257
7 Discussion The current immunohistochemical study of mucins allowed the characterization of Barrett intestinal metaplasia based on the content of MUC-1, MUC-2 and MUC-5AC mucins. Characteristic for these mucins is the fact that these are not normally expressed in oesophagus, MUC-1 being a breast type apomucin, MUC 2 - an intestinal apomucin unexpressed in normal gastric mucosa and MUC-5AC is a mucin of surface gastric epithelium. MUC-1, MUC-2 and MUC-5AC immunostaining showed cytoplasmic and membrane staining. MUC-1 positive immunostaining was focal and inconsistently present in Barrett's epithelium and was missing in the squamos neighborhood epithelium. It was unable to determine a direct correlation between MUC-1 immunostaining and the degree of associated dysplasia. In cases of junctional adenocarcinoma MUC-1 expression was highly positive in 3 cases of moderately differentiated adenocarcinoma - G2 (13%) and in 16 cases of poorly differentiated adenocarcinoma - G3 (100%). The results of this study showed that MUC- 1 immunohistochemical expression absent in squamous epithelium near Barrett's epithelium and constant present in all junctional adenocarcinomas G-3 describes a marker of aggressiveness of the lesion studied. Inconsistent presence of MUC-1 positive expression in Barrett's epithelium was not allowed his assession as a malignisation marker. Data from the literature describes the absence of MUC-1 expression in metaplasic and dysplasic Barrett's epithelium and his presence in adenocarcinoma fact that suggest suggest its usefulness in distinguishing dysplasia from adenocarcinoma (Chinyama et al., 1999, Guillem et al., 2000). MUC-2 immunostaining was consistently negative in Barrett's epithelium and near squamous epithelium and with positive 258 expression in all 4 cases of mucosecretant adenocarcinoma presented in the study. These results have not allowed to evaluate the clinical usefulness of MUC-2 immunostaining the precocious diagnosis of Barrett's esophagus-sequence-dysplasiaadenocarcinoma. It was noticed only the clear expression of MUC-2, an intestinal mucin, in mucinous adenocarcinoma, poorly differentiated. Our data are inconsistent with the literature, Chinyama et al. (1999), Guillem et al., (2000), describing the aberrant expression of MUC-2 in Barrett's intestinal mucosa, expressions that are lost when the epithelium becomes neoplasic. MUC-5AC mmunostaining (mucin of gastric surface epithelium) was diffusely and weakly positive in cases of chronic esophagitis and Barrett's epithelium. We could not establish a correlation between the intensity of MUC-5AC immunostaining and the degree of Barrett dysplasia. MUC-5AC expression was weakly positive in distal esophageal adenocarcinoma and moderately positive in the gastroesophageal adenocarcinoma junction. Moderately positive expression MUC-5AC was expressed in all gastro-oesophageal junction adenocarcinomas regardless of histopathological type of neoplasia. The results obtained have not allowed to evaluate the usefulness of MUC-5AC immunostaining in the precocious diagnosis of Barrett's oesophagus-sequencedysplasia-junction adenocarcinoma, however immunostaining could be useful for the differentiation of oesophageal adenocarcinomas from those of gastric cardia adenocarcinoma, the last one expressing more intense reactions of MUC- 5AC. However, we can not consider immunostaining MUC-5AC as a reliable marker in differentiating tumors according to location, since we observed positive expression in adenocarcinomas withhout associated Barrett's metaplasia and also in adenocarcinomas with associated Barrett's epithelium.
8 Conclusions We concluded that molecular biomarkers evolved in this study: MUC1, MUC 2 and MUC5AC mucins have just described already diagnosed aggressive neoplasia, showing no value in the precocious diagnosis of premalignant stages during Barrett's oesophagus sequence dysplasia adenocarcinoma junction. The current marker of the esophagogastric adenocarcinoma precocious diagnosis is dysplasia, and the mucins immunohistochemistry with cell cycle abnormalities and genetic changes studies may constitute the future preneoplastic screening methods. References Blot W.J., Devesa S.S., Kneller R.W., Fraumeni JF. Rising incidence of adenocarcinoma of the esophagus and gastric cardia JAMA, 265:1287 9, Chinyama C.N., Marshall R.E., Owen W.J., Expression of MUC1 and MUC2 mucin gene products in Barrett s metaplasia, dysplasia and adenocarcinoma: an immunopathological study with clinical correlation. Histopathology, 35:517 24, DeMeester S.R., DeMeester T.R. Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. Ann Surg; 231: , Guillem P., Billeret V., Buisine M.P., Mucin gene expression and cell differentiation in human normal, premalignant and malignant esophagus. Int. J. Cancer, 88: , Kim. R., Weissfeld J.L., Reyonalds J. C. and Kuller L.H. Etiology of Barrett s metaplasia and esophageal adenocarcinoma. Cancer Epidemiol. Biomarkers Prev., 6: , Lagergren J. Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk? Gut; 54 (Suppl. I):i1-i5, Riddell R.H., Goldman H., Ransohoff D.F.,. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum. Patho.l;14: , Roul A.,Parenti A.,Zaninotto G., Merigliano S., Constantini M.,Cagol M. Intestinal Metaplasia Is the Probable Common Precursor of Adenocarcinoma in Barrett Esophagus and Adenocarcinoma of the Gastric Cardia. American Cancer Society: , Sampliner RE. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett s esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am. J.Gastroenterol. ;93: , Spechler S.J., Goyal R.K. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. Gastroenterology;110: , Spechler S.J. Columnar-lined esophagus. Definitions. Chest Surg. Clin. N. Am.;12: 1 13, Weinstein WM, Ippoliti AF. The diagnosis of Barrett s esophagus: goblets, goblets, goblets. Gastrointest. Endosc. 1996;44: 91 5,
Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia
Gut 2000;46:9 13 9 PAPERS Division of Gastroenterology, University of Kansas, VA Medical Center, Kansas City, Missouri, USA P Sharma A P Weston Department of Pathology, VA Medical Center, Kansas M Topalovski
More informationBarrett s Esophagus: Old Dog, New Tricks
Barrett s Esophagus: Old Dog, New Tricks Stuart Jon Spechler, M.D. Chief, Division of Gastroenterology, VA North Texas Healthcare System; Co-Director, Esophageal Diseases Center, Professor of Medicine,
More informationHistopathology of Endoscopic Resection Specimens from Barrett's Esophagus
Histopathology of Endoscopic Resection Specimens from Barrett's Esophagus Br J Surg 38 oct. 1950 Definition of Barrett's esophagus A change in the esophageal epithelium of any length that can be recognized
More informationIs intestinal metaplasia a necessary precursor lesion for adenocarcinomas of the distal esophagus, gastroesophageal junction and gastric cardia?
Diseases of the Esophagus (2007) 20, 36 41 DOI: 10.1111/j.1442-2050.2007.00638.x Blackwell Publishing Asia Original article Is intestinal metaplasia a necessary precursor lesion for adenocarcinomas of
More informationBarrett s Esophagus. Abdul Sami Khan, M.D. Gastroenterologist Aurora Healthcare Burlington, Elkhorn, Lake Geneva, WI
Barrett s Esophagus Abdul Sami Khan, M.D. Gastroenterologist Aurora Healthcare Burlington, Elkhorn, Lake Geneva, WI A 58 year-old, obese white man has had heartburn for more than 20 years. He read a magazine
More informationAdenocarcinoma of the distal esophagus is a recognized
ORIGINAL ARTICLE Adenocarcinomas of the Distal Esophagus and Gastric Cardia Are Predominantly Esophageal Carcinomas Parakrama Chandrasoma, MD, Kumari Wickramasinghe, MD, PhD, Yanling Ma, MD, and Tom DeMeester,
More informationNew Developments in the Endoscopic Diagnosis and Management of Barrett s Esophagus
New Developments in the Endoscopic Diagnosis and Management of Barrett s Esophagus Prateek Sharma, MD Key Clinical Management Points: Endoscopic recognition of a columnar lined distal esophagus is crucial
More informationSAMs Guidelines DEVELOPING SELF-ASSESSMENT MODULES TEST QUESTIONS. Ver. #
SAMs Guidelines DEVELOPING SELF-ASSESSMENT MODULES TEST Ver. #5-02.12.17 GUIDELINES FOR DEVELOPING SELF-ASSESSMENT MODULES TEST The USCAP is accredited by the American Board of Pathology (ABP) to offer
More informationJoel A. Ricci, MD SUNY Downstate Medical Center Department of Surgery
Joel A. Ricci, MD SUNY Downstate Medical Center Department of Surgery Norman Barrett (1950) described the esophagus as: that part of the foregut, distal to the cricopharyngeal sphincter, which is lined
More informationHistory. Prevalence at Endoscopy. Prevalence and Reflux Sx. Prevalence at Endoscopy. Barrett s Esophagus: Controversy and Management
Barrett s Esophagus: Controversy and Management History Norman Barrett (1950) Chronic Peptic Ulcer of the Oesophagus and Oesophagitis Allison and Johnstone (1953) The Oesophagus Lined with Gastric Mucous
More informationFrequency of Barrett Esophagus in Patients with Symptoms of Gastroesophageal Reflux Disease
Original Article Frequency of Barrett Esophagus in Patients with Symptoms of Gastroesophageal Reflux Disease From Military Hospital, Rawalpindi Obaid Ullah Khan, Abdul Rasheed Correspondence: Dr. Abdul
More informationTHE AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 97, No. 1, by Am. Coll. of Gastroenterology ISSN /02/$22.00
THE AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 97, No. 1, 2002 2002 by Am. Coll. of Gastroenterology ISSN 0002-9270/02/$22.00 Published by Elsevier Science Inc. PII S0002-9270(01)03982-X ORIGINAL CONTRIBUTIONS
More informationIn 1998, the American College of Gastroenterology issued ALIMENTARY TRACT
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2012;10:1232 1236 ALIMENTARY TRACT Effects of Dropping the Requirement for Goblet Cells From the Diagnosis of Barrett s Esophagus MARIA WESTERHOFF,* LINDSEY HOVAN,
More informationGland ducts and multilayered epithelium in mucosal biopsies from gastroesophageal-junction region are useful in characterizing esophageal location
Diseases of the Esophagus (2005) 18, 87 92 2005 ISDE Blackwell Publishing, Ltd. Original article Gland ducts and multilayered epithelium in mucosal biopsies from gastroesophageal-junction region are useful
More informationGastrointestinal pathology 2018 lecture 2. Dr Heyam Awad FRCPath
Gastrointestinal pathology 2018 lecture 2 Dr Heyam Awad FRCPath Eosinophilic esophagitis Incidence of eosinophilic gastritis is increasing. Symptoms: food impaction and dysphagia. Histology: infiltration
More informationTable 2.9. Case control studies of helicobacter pylori infection and oesophageal adenocarcinoma
Characteristics of Characteristics of controls Detection Chow et al (1998) 1993-1995 129 of newly diagnosed oesophageal/gastric cardia (OGC) adenocarcinoma. 224 population controls selected by random digit
More informationSonic hedgehog expression in gastric cancer and gastric adenoma
ONCOLOGY REPORTS 17: 1051-1055, 2007 Sonic hedgehog expression in gastric cancer and gastric adenoma SUN-YOUNG LEE 1, HYE SEUNG HAN 2, KYUNG YUNG LEE 3, TAE SOOK HWANG 2, JEONG HWAN KIM 1, IN-KYUNG SUNG
More informationSAM PROVIDER TOOLKIT
THE AMERICAN BOARD OF PATHOLOGY Maintenance of Certification (MOC) Program SAM PROVIDER TOOLKIT Developing Self-Assessment Modules (SAMs) www.abpath.org The American Board of Pathology (ABP) approves educational
More informationOesophagus and Stomach update dysplasia and early cancer
Oesophagus and Stomach update dysplasia and early cancer Dr Tim Bracey STR teaching 13/4/16 Please check pathkids.com for previous talks One of the biggest units in the country (100 major resections per
More informationVital staining and Barrett s esophagus
Marcia Irene Canto, MD, MHS Baltimore, Maryland Vital staining or chromoendoscopy refers to staining of endoscopic tissue or topical application of chemical stains or pigments to alter tissue appearances
More informationPh.D. THESIS ENDOMETRIAL HYPERPLASIAS IN PERIMENOPAUSE SUMMARY
UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA FACULTY OF MEDICINE Ph.D. THESIS ENDOMETRIAL HYPERPLASIAS IN PERIMENOPAUSE SUMMARY SCIENTIFIC COORDINATOR: PROF. DR. MIHAI B. BRĂILA, Ph.D. Ph.D. Graduand:
More informationThe presence of intestinal-type goblet cells (ITGCs) in
Goblet Cell Mimickers in Esophageal Biopsies Are Not Associated With an Increased Risk for Dysplasia Mamoun Younes, MD; Atilla Ertan, MD; Gulchin Ergun, MD; Ray Verm, MD; Margaret Bridges, MD; Karen Woods,
More informationDefinition of GERD American College of Gastroenterology
Definition of GERD American College of Gastroenterology GERD is defined as chronic symptoms or mucosal damage produced by the abnormal reflux of gastric contents into the esophagus DeVault et al. Am J
More informationBarrett s Esophagus: Review of Diagnostic Issues and Pre- Neoplastic Lesions
Barrett s Esophagus: Review of Diagnostic Issues and Pre- Neoplastic Lesions Robert Odze, MD, FRCPC Chief, Gastrointestinal Pathology Associate Professor of Pathology Brigham and Women s Hospital Harvard
More informationThe normal esophagus is lined with squamous epithelium.
.. ALAN J. CAMERON, M.D. In Barrett's esophagus, the squamous lining of the lower esophagus is replaced by columnar epithelium. Barrett's esophagus is associated with gastroesophageal reflux and an increased
More informationPathology of the oesophagus and the stomach. Neil A Shepherd Gloucester, UK. Bristol Pathology 1 st Year Training School, The layers of the GI tract
Pathology of the oesophagus and the stomach Neil A Shepherd Gloucester, UK Bristol Pathology 1 st Year Training School, The layers of the GI tract 1 Some facts about Histopathology and the upper GI tract
More informationACG Clinical Guideline: Diagnosis and Management of Barrett s Esophagus
ACG Clinical Guideline: Diagnosis and Management of Barrett s Esophagus Nicholas J. Shaheen, MD, MPH, FACG 1, Gary W. Falk, MD, MS, FACG 2, Prasad G. Iyer, MD, MSc, FACG 3 and Lauren Gerson, MD, MSc, FACG
More informationCurrent Management: Role of Radiofrequency Ablation
Esophageal Adenocarcinoma And Barrett s Esophagus: Current Management: Role of Radiofrequency Ablation Ketan Kulkarni, MD Regional Gastroenterology Associates of Lancaster INTRODUCTION The prognosis of
More informationOesophageal Disorders
Oesophageal Disorders Anatomy Upper sphincter Oesophageal body Diaphragm Lower sphincter Gastric Cardia Symptoms Of Oesophageal Disorders Dysphagia Odynophagia Heartburn Atypical Chest Pain Regurgitation
More informationAdenocarcinoma of the Esophagogastric Junction and Barrett's Esophagus
GASTROENTEROLOGY 1995;109:1541-1546 Adenocarcinoma of the Esophagogastric Junction and Barrett's Esophagus ALAN J. CAMERON,* CLIFFORD T. LOMBOY,* MANUEL PERA,* and HERSCHEL A. CARPENTER g *Division of
More informationDOCTORAL THESIS (SUMMARY)
Translation from Romanian UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA THE FACULTY OF MEDICINE DOCTORAL THESIS (SUMMARY) Scientific coordinator Prof. Dr. Laurentiu MOGOANTA PhD student, Dr. Madalin IONILA
More informationFREQUENCY, TYPES AND COMPLICATIONS OF BARRETT S ESOPHAGUS IN PATIENTS WITH SYMPTOMS OF GASTRO-ESOPHAGEAL REFLUX
Original Article FREQUENCY, TYPES AND COMPLICATIONS OF BARRETT S ESOPHAGUS IN PATIENTS WITH SYMPTOMS OF GASTRO-ESOPHAGEAL REFLUX Ansari AL 1 & Sadiq S 2 ABSTRACT Objective: This study was carried out to
More informationGreater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy
Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy Authors: Dr Gordon Armstrong, Dr Sue Pritchard 1. General Comments 1.1 Cancer reporting: Biopsies
More informationAGA SECTION. Gastroenterology 2016;150:
Gastroenterology 2016;150:1026 1030 April 2016 AGA Section 1027 Procedural intervention (3) Upper endoscopy indications 3 6 Non-response of symptoms to a 4 8 week empiric trial of twice-daily PPI Troublesome
More informationIs Radiofrequency Ablation Effective In Treating Barrett s Esophagus Patients with High-Grade Dysplasia?
Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 12-2016 Is Radiofrequency Ablation Effective
More informationIntestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease?
Gut 1998;43:17 21 17 Gastroenterology, Hepatology, and Infectious Diseases A Hackelsberger V Schultze G Manes J-E Dominguez-Muñoz P Malfertheiner Pathology, Otto-von-Guericke University, Magdeburg, Germany
More informationThe Pathologist s Role in the Diagnosis and Management of Neoplasia in Barrett s Oesophagus Cian Muldoon, St. James s Hospital, Dublin
The Pathologist s Role in the Diagnosis and Management of Neoplasia in Barrett s Oesophagus Cian Muldoon, St. James s Hospital, Dublin 24.06.15 Norman Barrett Smiles [A brief digression - Chair becoming
More informationCD15 and CEA expression in thymic epithelial neoplasms
Turkish Journal of Cancer Volume 8, No., 8 CD and CEA expression in thymic epithelial neoplasms AYTEKİN AKYOL, AYŞEGÜL ÜNER Hacettepe University, Department of Pathology, Ankara-Turkey ABSTRACT The aim
More informationp53 Immunoreactivity in Barrett's metaplasia, dysplasia, and carcinoma
General Thoracic Surgery p53 Immunoreactivity in Barrett's metaplasia, dysplasia, and carcinoma Barrett's esophagus is a metaplastic condition with an unpredictable potential for neoplasia. Mutations of
More informationSingle and Multiplex Immunohistochemistry
Single and Multiplex Immunohistochemistry Steve Westra, BS Reagent Product Specialist Leica Biosystems IHC Theory Polyclonal vs Monoclonal Polyclonal reagents Detect a multitude of epitopes Batch to batch
More informationIMMUNOHISTOCHEMICAL ASSESSMENT OF ULCERATIVE COLITIS-RELATED DYSPLASIA Tiberia Ilias 1, O. Fratila 2, T. Maghiar 2, Dana Puscasiu 2
IMMUNOHISTOCHEMICAL ASSESSMENT OF ULCERATIVE COLITIS-RELATED DYSPLASIA Tiberia Ilias 1, O. Fratila 2, T. Maghiar 2, Dana Puscasiu 2 ¹ORADEA CLINICAL COUNTY HOSPITAL- 3 RD MEDICAL CLINIC ²UNIVERSITY OF
More informationTHE USE OF SPECIAL STAINS IN THE DIAGNOSIS OF BARRETT ESOPHAGUS AND BARRETT DYSPLASIA: RECOMMENDATIONS FROM THE RODGER C. HAGGITT GASTROINTESTINAL
THE USE OF SPECIAL STAINS IN THE DIAGNOSIS OF BARRETT ESOPHAGUS AND BARRETT DYSPLASIA: RECOMMENDATIONS FROM THE RODGER C. HAGGITT GASTROINTESTINAL PATHOLOGY SOCIETY Amitabh Srivastava 1, Henry Appelman
More informationBarrett esophagus. Bible class Inselspital
Barrett esophagus Bible class Inselspital 2015.08.10 Guidelines Definition? BSG: ACG: Definition? BSG: ACG: What are the arguments for and against IM as prerequisite for the Dg? What are the arguments
More informationExpression of the Tumour Suppressor Gene p53 in Odontogenic Cysts
Turk J Med Sci 33 (2003) 243-247 TÜB TAK CLINICAL INVESTIGATIONS Expression of the Tumour Suppressor Gene p53 in Odontogenic Cysts Ayla ÖZVEREN 1, Can TUSKAN 3, Mehmet YALTIRIK 3, Belir ATALAY 3, Gülçin
More informationORIGINAL ARTICLE. Adenocarcinoma of the Esophagus With and Without Barrett Mucosa
ORIGINAL ARTICLE Adenocarcinoma of the Esophagus With and Without Barrett Mucosa Michael S. Sabel, MD; Kate Pastore, MD; Hannah Toon, MD; Judy L. Smith, MD Hypothesis: Previous studies have demonstrated
More informationLearning Objectives:
Crescent City GI Update 2018 Ochsner Clinic, NOLA Optimizing Endoscopic Evaluation of Barrett s Esophagus What Should I Do in My Practice? Gregory G. Ginsberg, M.D. Professor of Medicine University of
More informationAnatomic and pathological aspects in the pathology of malignant gastric tumors
Romanian Journal of Morphology and Embryology 2006, 47(2):163 168 ORIGINAL PAPER Anatomic and pathological aspects in the pathology of malignant gastric tumors IZABELLA SARGAN 1), A. MOTOC 1), MONICA-ADRIANA
More informationStudy on prevalence of neoplastic lesions of the esophagus in patients referred to health centers of Ahvaz in the years
Available online at www.ijmrhs.com ISSN No: 29-5886 International Journal of Medical Research & Health Sciences, 26, 5, :5-54 Study on prevalence of neoplastic lesions of the esophagus in patients referred
More informationPresent Day Management of Barrett s Esophagus
Slide 1 Present Day Management of Barrett s Esophagus Kinnari R. Kher, M.D. Slide 2 Goals Risk factors for development of Barrett s esophagus Risks for progression to Esophageal Adenocarcinoma Current
More informationDOCTORAL THESIS SUMMARY
UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA DOCTORAL THESIS HISTOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL STUDY OF GASTRIC CARCINOMAS SUMMARY Scientific Coordinator: Univ. Prof. Dr. SIMIONESCU CRISTIANA EUGENIA
More informationNPQR Quality Payment Program (QPP) Measures 21_18247_LS.
NPQR Quality Payment Program (QPP) Measures 21_18247_LS MEASURE ID: QPP 99 MEASURE TITLE: Breast Cancer Resection Pathology Reporting pt Category (Primary Tumor) and pn Category (Regional Lymph Nodes)
More informationQuality ID #249 (NQF 1854): Barrett s Esophagus National Quality Strategy Domain: Effective Clinical Care
Quality ID #249 (NQF 1854): Barrett s Esophagus National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION: Percentage
More informationExpression of the GLUT1 and p53 Protein in Atypical Mucosal Lesions Obtained from Gastric Biopsy Specimens
The Korean Journal of Pathology 2006; 40: 32-8 Expression of the GLUT1 and p53 Protein in Atypical Mucosal Lesions Obtained from Gastric Biopsy Specimens In Gu Do Youn Wha Kim Yong-Koo Park Department
More informationQuality ID #249 (NQF 1854): Barrett s Esophagus National Quality Strategy Domain: Effective Clinical Care
Quality ID #249 (NQF 1854): Barrett s Esophagus National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY MEASURE TYPE: Process DESCRIPTION: Percentage
More informationEsophageal Adenocarcinoma Arising from Barrett s Epithelium in Taiwan
CSE REPORT Esophageal denocarcinoma rising from arrett s Epithelium in Taiwan Chia-Hung Tu, 1,2 Ching-Tai Lee, 1 Daw-Shyong Perng, 1 Chun-Chao Chang, 3 Chih-Hung Hsu, 4 Yi-Chia Lee 5,6 * The prevalence
More informationPattern of esophageal cancer in tertiary care hospital in North India: a clinicopathological study
International Journal of Research in Medical Sciences Gupta V et al. Int J Res Med Sci. 2017 Apr;5(4):1405-1409 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Original Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20171235
More information32 Adenocarcinoma of the oesophagogastric junction
Adenocarcinoma of the oesophagogastric junction S.J. Spechler P. Hainaut M.F. Dixon R. Lambert R. Genta R. Siewert Definition Adenocarcinomas that straddle the junction of the oesophagus and stomach are
More informationGreater Manchester & Cheshire Guidelines for Pathology Reporting of Oesophageal and Gastric Malignancy
Greater Manchester & Cheshire Guidelines for Pathology Reporting of Oesophageal and Gastric Malignancy Authors: Dr Stephen Hayes, Dr David Bisset, Dr Gordon Armstrong, Dr Sue Pritchard 1. General Comments
More informationHiatal Hernias and Barrett s esophagus. Dr Sajida Ahad Mercy General Surgery
Hiatal Hernias and Barrett s esophagus Dr Sajida Ahad Mercy General Surgery Objectives Identify the use of different diagnostic modalities for hiatal hernias List the different types of hiatal hernias
More informationMucin histochemistry of the columnar epithelium of the oesophagus: a retrospective study
J Clin Pathol 1981;34:866-870 Mucin histochemistry of the columnar epithelium of the oesophagus: a retrospective study JR JASS From the Department ofhistopathology, Westminster Medical School, Horseferry
More informationHistopathology: gastritis and peptic ulceration
Histopathology: gastritis and peptic ulceration These presentations are to help you identify, and to test yourself on identifying, basic histopathological features. They do not contain the additional factual
More informationGregory G. Ginsberg, M.D.
Radiofrequency Ablation for Barrett s Esophagus with HGD Gregory G. Ginsberg, M.D. Professor of Medicine University of Pennsylvania School of Medicine Abramson Cancer Center Gastroenterology Division Executive
More informationWT1, Estrogen Receptor, and Progesterone Receptor as Markers for Breast or Ovarian Primary Sites in Metastatic Adenocarcinoma to Body Fluids
Anatomic Pathology / WT1, ESTROGEN RECEPTOR, AND PROGESTERONE RECEPTOR IN CYTOLOGY OF BODY FLUIDS WT1, Estrogen Receptor, and Progesterone Receptor as Markers for Breast or Ovarian Primary Sites in Metastatic
More informationManagement of Barrett s Esophagus. Case Presentation
Management of Barrett s Esophagus Lauren B. Gerson MD, MSc Associate Clinical Professor, UCSF Director of Clinical Research Gastroenterology Fellowship Program California Pacific Medical Center San Francisco,
More informationCell Culture. The human thyroid follicular carcinoma cell lines FTC-238, FTC-236 and FTC-
Supplemental material and methods Reagents. Hydralazine was purchased from Sigma-Aldrich. Cell Culture. The human thyroid follicular carcinoma cell lines FTC-238, FTC-236 and FTC- 133, human thyroid medullary
More informationMyogenic Control. Esophageal Motility. Enteric Nervous System. Alimentary Tract Motility. Determinants of GI Tract Motility.
Myogenic Control Esophageal Motility David Markowitz, MD Columbia University, College of Physicians and Surgeons Basic Electrical Rythym: intrinsic rhythmic fluctuation of smooth muscle membrane potential
More informationEsophageal Motility. Alimentary Tract Motility
Esophageal Motility David Markowitz, MD Columbia University, College of Physicians and Surgeons Alimentary Tract Motility Propulsion Movement of food and endogenous secretions Mixing Allows for greater
More informationATLAS OF HEAD AND NECK PATHOLOGY METAPLASIA
Metaplasia is the conversion of one adult differentiated cell type to another. Generally it is the result of persistent cellular trauma and serves as a protective mechanism. Thus anteriorly along the nasal
More informationSerotonin- and Somatostatin-Positive Goblet Cell Carcinoid of the Duodenum
2012 66 4 351 356 Serotonin- and Somatostatin-Positive Goblet Cell Carcinoid of the Duodenum a b* c c c a a b d a c b d 352 Ohara et al. received remedies at another hospital. Hematemesis then recurred
More informationDavid Markowitz, MD. Physicians and Surgeons
Esophageal Motility David Markowitz, MD Columbia University, College of Columbia University, College of Physicians and Surgeons Alimentary Tract Motility Propulsion Movement of food and endogenous secretions
More informationL was termed Barrett s esophagus (BE) after the
ORIGINAL ARTICLES Barrett s Esophagus With High-Grade Dysplasia: An Indication for Esophagectomy? Manuel Pera, MD, Victor F. Trastek, MD, Herschel A. Carpenter, MD, Mark S. Allen, MD, Claude Deschamps,
More informationB. Cystic Teratoma: Refer to virtual microscope slide p_223 ovary, teratoma and compare to normal virtual microscope slide 086 ovary.
LAB 2: THE CONNECTIVE TISSUE AND EPITHELIUM The focus of this week s lab will be pathology of connective tissue and epithelium. The lab will introduce you to the four basic tissue types: epithelium, connective
More informationCLINICAL EFFECTIVENESS
Re-audit of gastrointestinal tract specimens with respect to compliance with RCPath guidelines Dr Manisha Ram Dr Moina Kadri Background epidemiology and aetiology Over the past 20 years there has been
More informationDuring the past 30 years, the incidence of esophageal ORIGINAL ARTICLES
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2006;4:38 43 ORIGINAL ARTICLES Optical Coherence Tomography to Identify Intramucosal Carcinoma and High-Grade Dysplasia in Barrett s Esophagus JOHN A. EVANS,* JOHN
More informationBarrett s esophagus. Barrett s neoplasia treatment trends
Options for endoscopic treatment of Barrett s esophagus Patrick S. Yachimski, MD MPH Director of Pancreatobiliary Endoscopy Assistant Professor of Medicine Division of Gastroenterology, Hepatology & Nutrition
More informationHistological Features of Gastric Cardia in Adults: an Autopsy
original PAPERs Histological Features of Gastric Cardia in Adults: an Autopsy Study Zorica M. Stojsic 1, Radmila M. Stevanovic 1, Martina M. Stojanovic 1, Aleksandar D. Stanojevic 2, Dragoljub T. Bacetic
More informationPatterns of E.cadherin and Estrogen receptor Expression in Histological Sections of Sudanese Patients with Breast Carcinoma
Patterns of E.cadherin and Estrogen receptor Expression in Histological Sections of Sudanese Patients with Breast Carcinoma Hadia. Mohammed. Abdalla. Abdalrhman *, Elsadig.A.Adam, Ayda.D.A.Allatif 3,'Namareg.E.Afadul
More informationBarrett s Esophagus and Barrett s-associated Neoplasia: Etiology and Pathologic Features
Barrett s Esophagus and Barrett s-associated Neoplasia: Etiology and Pathologic Features Domenico Coppola, MD, and Richard C. Karl, MD Enhancement of molecular markers and cytology may improve outcomes
More informationp53 expression in invasive pancreatic adenocarcinoma and precursor lesions
Malaysian J Pathol 2011; 33(2) : 89 94 ORIGINAL ARTICLE p53 expression in invasive pancreatic adenocarcinoma and precursor lesions NORFADZILAH MY MBBCH,* Jayalakshmi PAILOOR MPath, FRCPath,* RETNESWARI
More informationTHE CONNECTIVE TISSUE AND EPITHELIUM
THE CONNECTIVE TISSUE AND EPITHELIUM The focus of this week s lab will be pathology of connective tissue and epithelium. The lab will introduce you to the four basic tissue types: epithelium, connective
More informationPatterns of recurrent and persistent intestinal metaplasia after successful radiofrequency ablation of Barrett s esophagus
Patterns of recurrent and persistent intestinal metaplasia after successful radiofrequency ablation of Barrett s esophagus Robert J. Korst, MD, a,b Sobeida Santana-Joseph, MSN, a,b John R. Rutledge, MAS,
More informationIdentifying Intestinal Metaplasia at the Squamocolumnar Junction by Using Optical Coherence Tomography
Identifying Intestinal Metaplasia at the Squamocolumnar Junction by Using Optical Coherence Tomography The Harvard community has made this article openly available. Please share how this access benefits
More informationInterpretation Manual - Gastric or Gastroesophageal Junction Adenocarcinoma. PD-L1 IHC 22C3 pharmdx is FDA-approved for in vitro diagnostic use
Interpretation Manual - Gastric or Gastroesophageal Junction Adenocarcinoma PD-L1 IHC 22C3 pharmdx is FDA-approved for in vitro diagnostic use For countries outside of the United States, see the local
More informationOesophageal signet ring cell carcinoma as complication of gastro-oesophageal reflux disease
Alimentary Pharmacology and Therapeutics Oesophageal ring cell carcinoma as complication of gastro-oesophageal reflux disease K. O. Turner*,, R. M. Genta*,, & A. Sonnenberg, *Miraca Life Sciences Research
More informationValue of antimesothelioma HBME 1 in the diagnosis of inflammatory and malignant pleural effusions
Romanian Journal of Morphology and Embryology 2006, 47(4):351 355 ORIGINAL PAPER Value of antimesothelioma HBME 1 in the diagnosis of inflammatory and malignant pleural effusions LILIANA MOCANU 1), ANCA
More informationCorrelation of Vascular Endothelial Growth Factor Expression and Neovascularization with Colorectal Carcinoma: A Pilot Study
Research Article imedpub Journals http://www.imedpub.com Journal of Adenocarcinoma Vol. 1 No. 1:5 DOI: 10.21767/2572-309X.10005 Correlation of Vascular Endothelial Growth Factor Expression and Neovascularization
More informationEvaluating Treatments of Barrett s Esophagus That Shows High-Grade Dysplasia
...PRESENTATIONS... Evaluating Treatments of Barrett s Esophagus That Shows High-Grade Dysplasia Based on a presentation by Bergein F. Overholt, MD Presentation Summary Thermal ablation and surgery are
More informationRomanian Journal of Morphology and Embryology 2005, 46(4):
Romanian Journal of Morphology and Embryology 2005, 46(4):329 334 The value of serum and tissular expression of CA 125 antigen, in evaluation of the response to second line chemotherapy for the relapsed
More informationThis medical position statement considers a series of
GASTROENTEROLOGY 2011;140:1084 1091 American Gastroenterological Association Medical Position Statement on the Management of Barrett s Esophagus The Institute Medical Position Panel consisted of the authors
More informationCarcinoembryonic antigen (CEA)
Assessment Run 37 2013 Carcinoembryonic antigen (CEA) Material The slide to be stained for CEA comprised: 1. Appendix, 2. Liver, 3-4. Colon adenocarcinoma, 5. Urothelial carcinoma All tissues were fixed
More informationCorrelation Between Endoscopic and Histological Findings in Different Gastroduodenal Lesion and its Association with Helicobacter Pylori
ORIGINAL ARTICLE Correlation Between Endoscopic and Histological Findings in Different Gastroduodenal Lesion and its Association with Helicobacter Pylori *A. Sultana 1, SM Badruddoza 2, F Rahman 3 1 Dr.
More informationpylori gastritis are unclear. Methods 1058 consecutive dyspeptic patients
644 Gut 1999;45:644 648 PAPERS Complete and incomplete intestinal metaplasia at the oesophagogastric junction: prevalences and associations with endoscopic erosive oesophagitis and gastritis M Voutilainen,
More informationGI update. Common conditions and concerns my patients frequently asked about
GI update Common conditions and concerns my patients frequently asked about Specific conditions I ll try to cover today 1. Colon polyps, colorectal cancer and colonoscopy 2. Crohn s disease 3. Peptic ulcer
More informationParis classification (2003) 삼성의료원내과이준행
Paris classification (2003) 삼성의료원내과이준행 JGCA classification - Japanese Gastric Cancer Association - Type 0 superficial polypoid, flat/depressed, or excavated tumors Type 1 polypoid carcinomas, usually attached
More informationFaculty Disclosure. Objectives. State of the Art #3: Referrals for Gastroscopy (focus on common esophagus problems) 24/11/2014
State of the Art #3: Referrals for Gastroscopy (focus on common esophagus problems) Dr. Amy Morse November 2014 Faculty: Amy Morse Faculty Disclosure Relationships with commercial interests: Grants/Research
More informationCommon Inflammatory Gastrointestinal Disorders: Endoscopic and Pathologic Correlations
Common Inflammatory Gastrointestinal Disorders: Endoscopic and Pathologic Correlations Nicole C. Panarelli, M.D. Attending Pathologist Montefiore Medical Center Associate Professor of Pathology - Albert
More informationEsophageal cancer: Biology, natural history, staging and therapeutic options
EGEUS 2nd Meeting Esophageal cancer: Biology, natural history, staging and therapeutic options Michael Bau Mortensen MD, Ph.D. Associate Professor of Surgery Centre for Surgical Ultrasound, Upper GI Section,
More informationBarrett s Esophagus. lining of the lower esophagus that bears his name (i.e., Barrett's esophagus). We now
Shamika Johnson Anatomy & Physiology 206 April 20, 2010 Barrett s Esophagus What is Barrett s Esophagus? Norman Barrett was a pathologist. In 1950, he described an abnormality in the lining of the lower
More informationLIST OF ABBREVIATIONS
Gastroenter oenterology 2005 Royal College of Physicians of Edinburgh Screening and surveillance for upper and lower gastrointestinal cancer JN Plevris Consultant Gastroenterologist and Honorary Senior
More informationIntestinal Metaplasia of the Esophagus or Esophagogastric Junction Evidence of Distinct Clinical, Pathologic, and Histochemical Staining Features
Anatomic Pathology / ESOPHAGEAL AND JUNCTIONAL INTESTINAL METAPLASIA Intestinal Metaplasia of the Esophagus or Esophagogastric Junction Evidence of Distinct Clinical, Pathologic, and Histochemical Staining
More information